InvestorsHub Logo
Followers 829
Posts 119629
Boards Moderated 14
Alias Born 09/05/2002

Re: samk post# 27955

Friday, 07/28/2017 8:59:06 PM

Friday, July 28, 2017 8:59:06 PM

Post# of 108192
ADXS has roughly three quarters of operating cash (#msg-133219185), which is cutting it pretty close, even after allowing for milestone payments from AMGN (#msg-133292350).

AXAL approval in the EU is far from assured.

If ADXS were to wait, say, 6 months to finance, the stock market could conceivably be in a tailspin that is not conducive to raising capital. This is an issue not only for ADXS, but also for biotech stocks in general—e.g. RVNC (#msg-132973720).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News